Abstract

BACKGROUND: The current evidence on effect of fluoridation in drinking water on bone is inconsistent. This study was undertaken to assess the effect of fluoride concentration in drinking water on bone mineral density (BMD) in Taiwanese women. METHODS: The study subjects included 248 women aged > or = 40 years who reside in naturally fluoridated and adjacent areas. The individual fluoride concentration of the drinking water and the BMD of the subjects’ lumbar spines were assessed. RESULTS: Women aged 46-65 years living in areas which have fluoride levels < 0.6 mg/l (mean = 0.18 mg/l; n = 130) had slightly lower bone densities than women living in areas with levels > or = 0.6 mg/l (mean 0.98 mg/l, n = 118). Only the age groups 46-50 and 61-65 years proved to be statistically significant. After controlling for age and body mass index, the BMD of those who had a dose > or = 1.0 mg/l is notably higher than the reference group (< or = 0.6 mg/l). After stratification by menopausal status, fluoride appeared to have no association with bone density in postmenopausal women. CONCLUSIONS: The BMD of the subjects from the area with a fluoride dose > 1 mg/l were significantly higher than those from the reference group (fluoride < 0.6 mg/l) for premenopausal women. There is no significant association between BMD and fluoride for postmenopausal women in Taiwan.

• Related Studies :

  • Radiological spectrum of endemic fluorosis: relationship with calcium intake

    Skeletal fluorosis continues to be endemic in many parts of India. Osteosclerosis and interosseous membrane calcification have long been regarded as hallmarks of this disease. Our study showed in addition a wide variety of radiological patterns: coarse trabecular pattern, axial osteosclerosis with distal osteopenia and diffuse osteopenia. Subjects with osteopenic changes had

  • The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride

    Forty-eight female patients with postmenopausal osteoporotic vertebral compression fractures were treated with sodium fluoride and calcium supplements; their response to treatment was documented by sequential measurements of vertebral and forearm bone mineral density (BMD). During treatment 25 patients developed significant side-effects due to fluoride, and ultimately, 18 patients (37%) were

  • Effects of fluoride treatment on bone strength

    Bone mass and architecture in appendicular and most axial sites is controlled primarily by the tissue-loading history. We introduce a conceptual framework for understanding how fluoride treatment alters this control and can cause systemic increases in bone mass. Due to possible adverse influences of fluoride on the mineralized tissue physical

  • Efficacy and Safety of Postmenopausal Osteoporosis Treatments: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

    Although a range of pharmacological interventions is available, it remains uncertain which treatment for osteoporosis is more effective. This network meta-analysis study aimed to compare different drug efficacy and safety in randomized controlled trials (RCTs) for the treatment of postmenopausal osteoporosis. PubMed, EMBASE, MEDLINE, Clinicaltrial.gov, Cochrane library, Google scholar were

  • High fluoride and low calcium levels in drinking water is associated with low bone mass, reduced bone quality and fragility fractures in sheep

    Chronic environmental fluoride exposure under calcium stress causes fragility fractures due to osteoporosis and bone quality deterioration, at least in sheep. Proof of skeletal fluorosis, presenting without increased bone density, calls for a review of fracture incidence in areas with fluoridated groundwater, including an analysis of patients with low bone

• Related FAN Content :

  • Fluoride & Osteoarthritis

    While the osteoarthritic effects that occurred from fluoride exposure were once considered to be limited to those with skeletal fluorosis, recent research shows that fluoride can cause osteoarthritis in the absence of traditionally defined fluorosis. Conventional methods used for detecting skeletal fluorosis, therefore, will fail to detect the full range of people suffering from fluoride-induced osteoarthritis.

  • Skeletal Fluorosis: The Misdiagnosis Problem

    It is a virtual certainty that there are individuals in the general population unknowingly suffering from some form of skeletal fluorosis as a result of a doctor's failure to consider fluoride as a cause of their symptoms. Proof that this is the case can be found in the following case reports of skeletal fluorosis written by doctors in the U.S. and other western countries. As can be seen, a consistent feature of these reports is that fluorosis patients--even those with crippling skeletal fluorosis--are misdiagnosed for years by multiple teams of doctors who routinely fail to consider fluoride as a possible cause of their disease.

  • "Pre-Skeletal" Fluorosis

    As demonstrated by the studies below, skeletal fluorosis may produce adverse symptoms, including arthritic pains, clinical osteoarthritis, gastrointestinal disturbances, and bone fragility, before the classic bone change of fluorosis (i.e., osteosclerosis in the spine and pelvis) is detectable by x-ray. Relying on x-rays, therefore, to diagnosis skeletal fluorosis will invariably fail to protect those individuals who are suffering from the pre-skeletal phase of the disease. Moreover, some individuals with clinical skeletal fluorosis will not develop an increase in bone density, let alone osteosclerosis, of the spine. Thus, relying on unusual increases in spinal bone density will under-detect the rate of skeletal fluoride poisoning in a population.